Palisade Bio
PALI
5 hedge funds and large institutions have $1.21M invested in Palisade Bio in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more ownership
Funds ownership: 0% → 0% (0%)
4% less capital invested
Capital invested by funds: $1.26M → $1.21M (-$45.1K)
Top Buyers
Top Sellers
PALI Hedge Fund Activity: Q3 2018 in Review
5 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2018, worth a combined $1.21M — down 3.6% from $1.26M a quarter earlier.
Fund positioning in PALI was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 5 institutional investors held Palisade Bio (PALI) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $1.21M of Palisade Bio stock for Q3 2018, down 3.6% quarter-over-quarter.
- 0 funds opened new Palisade Bio positions in Q3 2018 and 0 closed out.
Based on aggregated 13F filings for Q3 2018.